Chimera Investment (CIM) has drawn attention after recent share performance data, with the stock last closing at US$13.54 and showing mixed returns over the past week, month and past 3 months.
See our latest analysis for Chimera Investment.
Recent trading has been choppy, with a 1-day share price return of -0.66% and a 7-day share price return of -1.53%. At the same time, the 1-year total shareholder return of 19.27% and 3-year total shareholder return of 26.61% indicate momentum that has been building over a longer horizon.
If Chimera Investment has you thinking about income and specialty finance opportunities, it could be worth broadening your research through 18 top founder-led companies
With Chimera Investment trading at US$13.54, a value score of 1, a 6.6% intrinsic discount and a roughly 10% gap to its analyst price target, you have to ask: is this a buying opportunity, or is the market already pricing in future growth?
Chimera Investment's most followed narrative sets a fair value of $14.50 per share, a touch above the last close of $13.54, framing the stock as modestly undervalued on a discounted cash flow view.
The acquisition of HomeXpress, a leading non-QM originator, is expected to be materially accretive to earnings in 2026 and 2027, aligning with the ongoing expansion of the non-agency and non-QM mortgage markets. This is expected to directly drive revenue growth and enhance return on equity.
Want to see what sits behind that valuation gap? The narrative focuses on faster revenue growth, rising margins, and a future earnings profile that is expected to look very different from today.
Result: Fair Value of $14.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are real tensions here, including higher credit risk from non-QM exposure and increased reliance on short-term repo funding, which could quickly pressure margins.
Find out about the key risks to this Chimera Investment narrative.
While the SWS DCF model points to Chimera Investment trading about 6.6% below its estimated fair value, the revenue multiple paints a tougher picture. The current P/S of 5.3x is higher than the US Mortgage REITs industry at 4.8x, the peer average at 2.8x, and the fair ratio of 3.2x. This suggests less room for error if growth or margins fall short. So which signal do you trust more, the cash flow model or the revenue multiple?
See what the numbers say about this price — find out in our valuation breakdown.
Mixed signals on value and risk so far? Take a moment to review the data yourself, and then weigh up the stock using our 2 key rewards and 2 important warning signs
If Chimera Investment has sharpened your focus, do not stop here. Widening your research set now can help you spot opportunities others might overlook.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com